According to the National Cancer Institute, one in eight women may be diagnosed with breast cancer at some time during their life1. Women whose breast cancer is detected at an early stage have on average a 90% survival rate in the first five years2.
The key is to find the disease early so treatment can start earlier.
At Fujifilm, we know that mammograms don’t work if women don’t get them; that is why we are dedicated to providing a noticeably more comfortable mammogram3 equipped with the latest advancements in imaging, including digital breast tomosynthesis (DBT).
Image quality is critical to detecting tumors, especially small ones at the early stage. The addition of DBT adds even higher diagnostic capabilities to help physicians diagnose cancers earlier for better patient outcomes, while striving to keep radiation dose as low as possible.
In an effort to improve the patient experience, the system also includes an exclusive ‘Comfort Paddle’ designed to conform to the natural shape of the breast, reducing pressure at the chest wall side with the goal of ensuring the most even and adequate compression so women come back time and time again for this much-needed exam.
In an effort to promote women’s health, we are traveling across the 48 contiguous U.S. states in our ‘Aspire to Be Fearless’ mobile mammography coach, which is outfitted with the ASPIRE Cristalle 3D mammography system and a Bellus II mammography workstation. Our coach hosts educational opportunities for clinicians, raises awareness about the importance of screening, and seeks clinical partners to provide mammograms to underserved populations in key locations.
We are committed to improving women’s health by improving access to breast health education and mammography screening services for every woman who needs it.
Fujifilm is committed to supporting technologists with continuing education offerings. Select from multiple webinar options to view and acquire CE credits.
This webinar will provide the audience with a unique perspective, that of a Medical Physicist, when evaluating and considering mammography systems from four different vendors. Discussion topics include elements to consider for a reliable mammography system, understanding the technology and system testing differences between each vendor, and the importance of an efficient QC testing process upon installation.
In this Expert Forum, Dr. Matthew Covington shares his understanding of the benefits and limitations of contrast-enhanced mammography, as compared to contrast-enhanced breast MRI, and how this imaging technique can be incorporated into clinical practice.
Dr. Laurie Fajardo will share her understanding of the benefits of synthetic 2D images with digital breast tomosynthesis (DBT) for diagnosing breast cancer along with considerations for implementing Synthetic 2D breast imaging protocols into your practice.
1 “Breast Cancer Risk in American Women.” National Cancer Institute. Retrieved from https://www.cancer.gov/types/breast/risk-fact-sheet
2 Retrieved from https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancerdiagnosis/
breast-cancer-survival-rates.html
3FUJIFILM. “COMFORT COMP– Prioritizing patient comfort during mammography [White Paper].” www.fujimed.com. October 10, 2022.
